LAIR-2 Compositions and Methods
Abstract:
Provided herein are compositions and methods comprising Leukocyte-associated immunoglobulin-like receptor 2 (LAIR-2) and a Fc domain. Further provided herein are compositions and methods comprising TNT antibody fused to a TGFβ trap. The compositions and methods provided herein are useful for modulating a collagen matrix in a solid tumor.
Information query
Patent Agency Ranking
0/0